PERIPHERAL PARENTERAL NUTRITION recall
FDA recall D-0530-2025 · initiated Jul 1, 2025
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalled PERIPHERAL PARENTERAL NUTRITION in Jul 2025 — an FDA Class II recall (D-0530-2025) because Lack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Lack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.
The manufacturing process itself
The FDA found the process itself out of compliance, usually before any defective product was identified.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 2 bags
Details
- Product
- PERIPHERAL PARENTERAL NUTRITION, Compounded Sterile Preparation, Refrigerated Injection, Rx Only, Single Dose Injection, a) 1440 mL bag, b) 1700 mL bag, Central Admixture Pharmacy Services, Inc, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90870.
- Recalling company
- Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- CA
- Initiated
- Jul 1, 2025
- FDA report date
- Jul 23, 2025
Frequently asked
- Was PERIPHERAL PARENTERAL NUTRITION recalled?
- Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalled PERIPHERAL PARENTERAL NUTRITION in Jul 2025 — an FDA Class II recall (D-0530-2025) because Lack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was PERIPHERAL PARENTERAL NUTRITION recalled?
- Per the FDA enforcement record, the reason for recall D-0530-2025 was: Lack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.
- Is a recalled PERIPHERAL PARENTERAL NUTRITION dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of PERIPHERAL PARENTERAL NUTRITION are affected?
- Distributed: CA. The recall covers these lots — Lot: a) 11-4785290-0-1, BUD: 6/19/2025 @ 11:32 pm; b) 11-4785217-0-1, BUD: 6/19/2025 @ 10:25 pm.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0530-2025.